{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T22:55:51Z","timestamp":1786575351499,"version":"build-2736575974"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000008","name":"Health Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000008","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Individuals living with chronic conditions (CC) typically have a higher risk of more severe outcomes when exposed to infection. Although many studies have investigated the relationship between CCs and COVID-19 severity, they are generally limited to clinical or hospitalized populations. There is a need to estimate the impact of pre-existing CCs on the severity of acute SARS-CoV-2 infection symptoms among the general population.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Data from the Canadian COVID-19 Antibody and Health Survey \u2013 Cycle 2, a population-based cross-sectional probability survey across 10 provinces capturing the COVID-19 experiences of respondents from January 2020 to August 2022, were used to assess whether pre-existing CCs increased the odds of more severe self-reported infection symptoms among adults living in Canada. Multivariable regression modelling identified which CCs were independently associated with more severe infection symptoms after adjusting for sex, age at infection, and other significant covariates.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Chronic lung disease (aOR\u2009=\u20091.64, 95% CI: 1.09, 2.46), high blood pressure (aOR\u2009=\u20091.35, 95% CI: 1.13, 1.62), weakened immune system (aOR\u2009=\u20091.46, 95% CI: 1.08, 1.98), chronic fatigue syndrome or fibromyalgia (aOR\u2009=\u20092.20, 95% CI: 1.39, 3.50), and arthritis (aOR\u2009=\u20091.28, 95% CI: 1.04, 1.56) were associated with a higher odds of more severe infection, whereas osteoporosis (aOR\u2009=\u20090.58, 95% CI: 0.39, 0.87) was associated with a lower odds. Limiting modelling to adults with confirmed SARS-CoV-2 infections affected some of the variables retained and adjusted associations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Our findings contribute to a growing evidence base of associations between pre-existing CCs and adverse outcomes after SARS-CoV-2 infection. Identifying factors associated with more severe infection allows for more targeted prevention strategies and early interventions that can minimize the impact of infection.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12889-025-22041-7","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T17:11:53Z","timestamp":1741799513000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between pre-existing chronic conditions and severity of first SARS-CoV-2 infection symptoms among adults living in Canada: a population-based survey analysis from January 2020 to August 2022"],"prefix":"10.1186","volume":"25","author":[{"given":"Nicholas","family":"Cheta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianne","family":"Zakaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Demers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peri","family":"Abdullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samina","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"#cr-split#-22041_CR1.1","unstructured":"World Health Organization (WHO). WHO Director-General's opening remarks at the media briefing on COVID-19-11 March 2020 [Internet]. Geneva: WHO"},{"key":"#cr-split#-22041_CR1.2","unstructured":"2020 [cited 2024 Feb 16]. Available from: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020"},{"key":"22041_CR2","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.230249","author":"TJ Murphy","year":"2023","unstructured":"Murphy TJ, Swail H, Jain J, Anderson M, Awadalla A, Behl L, Brown PE, Charlton CL, Colwill K, Drews SJ, Gingras AC, Hinshaw D, Jha P, Kanji JN, Kirsh VA, Lang ALS, Langlois MA, Lee S, Lewin A, O\u2019Brien SF, Pambrun C, Skead K, Stephens DA, Stein DR, Tipples G, Van Caeseele PG, Evans TG, Oxlade O, Mazer BD, Buckeridge DL. The evolution of SARS-CoV-2 Seroprevalence in Canada: a time-series study, 2020\u20132023. CMAJ. 2023. https:\/\/doi.org\/10.1503\/cmaj.230249.","journal-title":"CMAJ"},{"key":"22041_CR3","doi-asserted-by":"publisher","DOI":"10.1177\/00368504211019854","author":"H Onyeaka","year":"2021","unstructured":"Onyeaka H, Anumudu CK, Al-Sharify ZT, Egele-Godswill E, Mbaegbu P. COVID-19 pandemic: A review of the global lockdown and its far-reaching effects. Sci Prog. 2021. https:\/\/doi.org\/10.1177\/00368504211019854.","journal-title":"Sci Prog"},{"key":"22041_CR4","doi-asserted-by":"publisher","DOI":"10.1093\/geronb\/gbaa096","author":"P Klaiber","year":"2021","unstructured":"Klaiber P, Wen JH, DeLongis A, Sin NL. The ups and downs of daily life during COVID-19: age differences in affect, stress, and positive events. J Gerontol B Psychol Sci Soc Sci. 2021. https:\/\/doi.org\/10.1093\/geronb\/gbaa096.","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"22041_CR5","doi-asserted-by":"publisher","unstructured":"Ammar A, Chtourou H, Boukhris O, Trabelsi K, Masmoudi L, Brach M, Bouaziz B, Bentlage E, How D, Ahmed M, Mueller P, Mueller N, Hsouna H, Aloui A, Hammouda O, Paineiras-Domingos LL, Braakman-Jansen A, Wrede C, Bastoni S, Pernambuco CS, Mataruna L, Taheri M, Irandoust K, Khacharem A, Bragazzi NL, Strahler J, Washif JA, Andreeva A, Khoshnami SC, Samara E, Zisi V, Sankar P, Ahmed WN, Romdhani M, Delhey J, Bailey SJ, Bott NT, Gargouri F, Chaari L, Batatia H, Ali GM, Abdelkarim O, Jarraya M, El Abed K, Souissi N, Van Gemert-Pijnen L, Riemann BL, Riemann L, Moalla W, G\u00f3mez-Raja J, Epstein M, Sanderman R, Schulz S, Jerg A, Al-Horani R, Mansi T, Jmail M, Barbosa F, Ferreira-Santos F, \u0160imuni\u010d B, Pi\u0161ot R, Pi\u0161ot S, Gaggioli A, Zmijewski P, Apfelbacher C, Steinacker J, Ben Saad H, Glenn JM, Chamari K, Driss T, Hoekelmann A. On behalf of the ECLB-COVID consortium. COVID-19 home confinement negatively impacts social participation and life satisfaction: A worldwide multicenter study. International Journal of Environmental Research and Public Health; 2020. https:\/\/doi.org\/10.3390\/ijerph17176237.","DOI":"10.3390\/ijerph17176237"},{"key":"22041_CR6","unstructured":"Public Health Agency of Canada. From risk to resilience: An equity approach to COVID-19 [Internet], Ottawa PHAC. 2024 [cited 2024 Mar 1]. Available from: https:\/\/www.canada.ca\/en\/public-health\/corporate\/publications\/chief-public-health-officer-reports-state-public-health-canada\/from-risk-resilience-equity-approach-covid-19.html#a2.2"},{"key":"22041_CR7","unstructured":"Kuang S, Earl S, Clarke J, Zakaria D, Demers A, Aziz S. Experiences of Canadians with long-term symptoms following COVID-19. Insights on Canadian Society [Internet]. 2023 Dec 8 [cited 2024 Feb 16]. Available from: https:\/\/www150.statcan.gc.ca\/n1\/pub\/75-006-x\/2023001\/article\/00015-eng.htm"},{"key":"22041_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30978-6","author":"M Drozd","year":"2021","unstructured":"Drozd M, Pujades-Rodriguez M, Lillie PJ, Straw S, Morgan AW, Kearney MT, Witte KK, Cubbon RM. Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK biobank observational cohort study. Lancet Infect Dis. 2021. https:\/\/doi.org\/10.1016\/S1473-3099(20)30978-6.","journal-title":"Lancet Infect Dis"},{"key":"22041_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2020.100617","author":"G Aggarwal","year":"2020","unstructured":"Aggarwal G, Cheruiyot I, Aggarwal S, Wong J, Lippi G, Lavie CJ, Henry BM, Sanchis-Gomar F. Association of cardiovascular disease with coronavirus disease 2019 (COVID-19) severity: A Meta-Analysis. Curr Probl Cardiol. 2020. https:\/\/doi.org\/10.1016\/j.cpcardiol.2020.100617.","journal-title":"Curr Probl Cardiol"},{"key":"22041_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2022.08.011","author":"YA Arif","year":"2022","unstructured":"Arif YA, Stefanko AM, Garcia N, Beshai DA, Fan W, Wong ND. Estimated atherosclerotic cardiovascular disease risk: disparities and severe COVID-19 outcomes (from the National COVID cohort Collaborative). Am J Cardiol. 2022. https:\/\/doi.org\/10.1016\/j.amjcard.2022.08.011.","journal-title":"Am J Cardiol"},{"key":"22041_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2023-002415","author":"SG Williams","year":"2023","unstructured":"Williams SG, Frain S, Guo H, Carr MJ, Ashcroft DM, Keavney BD. Clinical risk associated with COVID-19 among 86000 patients with congenital heart disease. Open Heart. 2023. https:\/\/doi.org\/10.1136\/openhrt-2023-002415.","journal-title":"Open Heart"},{"key":"22041_CR12","doi-asserted-by":"publisher","unstructured":"McGurnaghan SJ, Weir A, Bishop J, Kennedy S, Blackbourn LAK, McAllister DA, Hutchinson S, Caparrotta TM, Mellor J, Jeyam A, O\u2019Reilly JE, Wild SH, Hatam S, H\u00f6hn A, Colombo M, Robertson C, Lone N, Murray J, Butterly E, Petrie J, Kennon B, McCrimmon R, Lindsay R, Pearson E, Sattar N, McKnight J, Philip S, Collier A, McMenamin J, Smith-Palmer A, Goldberg D, McKeigue PM, Colhoun HM, Scottish Diabetes Research Network Epidemiology Group. Public Health Scotland COVID-19 Health Protection Study Group,. Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland. The Lancet Diabetes & Endocrinology. 2020; https:\/\/doi.org\/10.1016\/S2213-8587(20)30405-8","DOI":"10.1016\/S2213-8587(20)30405-8"},{"key":"22041_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1025699","author":"JV Stidsen","year":"2022","unstructured":"Stidsen JV, Green A, Rosengaard L, H\u00f8jlund K. Risk of severe COVID-19 infection in persons with diabetes during the first and second waves in Denmark: A nationwide cohort study. Front Endocrinol. 2022. https:\/\/doi.org\/10.3389\/fendo.2022.1025699.","journal-title":"Front Endocrinol"},{"key":"22041_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-021-01110-1","author":"KS Boye","year":"2021","unstructured":"Boye KS, Tokar Erdemir E, Zimmerman N, Reddy A, Benneyworth BD, Dabora MC, Hankosky ER, Bethel MA, Clark C, Lensing CJ, Sailer S, San Juan R, Heine RJ, Etemad L. Risk factors associated with COVID-19 hospitalization and mortality: A large Claims-Based analysis among people with type 2 diabetes mellitus in the united States. Diabetes Ther. 2021. https:\/\/doi.org\/10.1007\/s13300-021-01110-1.","journal-title":"Diabetes Ther"},{"key":"22041_CR15","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.2274","author":"G Fond","year":"2021","unstructured":"Fond G, Nemani K, Etchecopar-Etchart D, Loundou A, Goff DC, Lee SW, Lancon C, Auquier P, Baumstarck K, Llorca PM, Yon DK, Boyer L. Association between mental health disorders and mortality among patients with COVID-19 in 7 countries: A systematic review and Meta-analysis. JAMA Psychiatry. 2021. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.2274.","journal-title":"JAMA Psychiatry"},{"key":"22041_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01344-2","author":"L Hassan","year":"2021","unstructured":"Hassan L, Peek N, Lovell K, Carvalho AF, Solmi M, Stubbs B, Firth J. Disparities in COVID-19 infection, hospitalisation and death in people with schizophrenia, bipolar disorder, and major depressive disorder: a cohort study of the UK biobank. Mol Psychiatry. 2021. https:\/\/doi.org\/10.1038\/s41380-021-01344-2.","journal-title":"Mol Psychiatry"},{"key":"22041_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106349","author":"T Kubota","year":"2021","unstructured":"Kubota T, Kuroda N. Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: A systematic review. Clin Neurol Neurosurg. 2021. https:\/\/doi.org\/10.1016\/j.clineuro.2020.106349.","journal-title":"Clin Neurol Neurosurg"},{"key":"22041_CR18","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-220031","author":"SJ Chung","year":"2022","unstructured":"Chung SJ, Chang Y, Jeon J, Shin JI, Song TJ, Kim J. Associations of Alzheimer\u2019s disease with COVID-19 susceptibility and severe complications: A nationwide cohort study. J Alzheimer\u2019s Disease. 2022. https:\/\/doi.org\/10.3233\/JAD-220031.","journal-title":"J Alzheimer\u2019s Disease"},{"key":"22041_CR19","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200195","author":"J Yoo","year":"2022","unstructured":"Yoo J, Kim JH, Jeon J, Kim J, Song TJ. Risk of COVID-19 infection and of severe complications among people with epilepsy. Neurology. 2022. https:\/\/doi.org\/10.1212\/WNL.0000000000200195.","journal-title":"Neurology"},{"key":"22041_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(22)00227-2","author":"G Figueroa-Parra","year":"2022","unstructured":"Figueroa-Parra G, Gilbert EL, Valenzuela-Almada MO, Vallejo S, Neville MR, Patel NJ, Cook C, Fu X, Hagi R, McDermott GC, Dilorio MA, Masto L, Vanni KMM, Kowalski E, Qian G, Zhang Y, Wallace ZS, Duarte-Garc\u00eda A, Sparks JA. Risk of severe COVID-19 outcomes associated with rheumatoid arthritis and phenotypic subgroups: a retrospective, comparative, multicentre cohort study. Lancet Rheumatol. 2022. https:\/\/doi.org\/10.1016\/S2665-9913(22)00227-2.","journal-title":"Lancet Rheumatol"},{"key":"22041_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268688","author":"A Sato","year":"2022","unstructured":"Sato A, Ludwig J, Howell T. A retrospective cohort study on COVID-19 at 2 Los Angeles hospitals: older age, low triage oxygenation, and chronic kidney disease among the top risk factors associated with in-hospital mortality. PLoS ONE. 2022. https:\/\/doi.org\/10.1371\/journal.pone.0268688.","journal-title":"PLoS ONE"},{"key":"22041_CR22","doi-asserted-by":"publisher","DOI":"10.1177\/2473974X211016283","author":"MB Kravitz","year":"2021","unstructured":"Kravitz MB, Yakubova E, Yu N, Park SY. Severity of sleep apnea and COVID-19 illness. OTO Open. 2021. https:\/\/doi.org\/10.1177\/2473974X211016283.","journal-title":"OTO Open"},{"key":"22041_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s11325-020-02203-0","author":"MB Maas","year":"2020","unstructured":"Maas MB, Kim M, Malkani RG, Abbott SM, Zee PC. Obstructive sleep apnea and risk of COVID-19 infection, hospitalization, and respiratory failure. Sleep Breath. 2020. https:\/\/doi.org\/10.1007\/s11325-020-02203-0.","journal-title":"Sleep Breath"},{"key":"22041_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-044684","author":"A Wingert","year":"2021","unstructured":"Wingert A, Pillay J, Gates M, Guitard S, Rahman S, Beck A, Vandermeer B, Hartling L. Risk factors for severity of COVID-19: a rapid review to inform vaccine prioritisation in Canada. BMJ Open. 2021. https:\/\/doi.org\/10.1136\/bmjopen-2020-044684.","journal-title":"BMJ Open"},{"key":"22041_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2021-111788","author":"A Otunla","year":"2022","unstructured":"Otunla A, Rees K, Dennison P, Hobbs R, Suklan J, Schofield E, Gunnell J, Mighiu A, Hartmann-Boyce J. Risks of infection, hospital and ICU admission, and death from COVID-19 in people with asthma: systematic review and meta-analyses. BMJ Evidence-Based Med. 2022. https:\/\/doi.org\/10.1136\/bmjebm-2021-111788.","journal-title":"BMJ Evidence-Based Med"},{"key":"22041_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2022.107064","author":"LC Myers","year":"2023","unstructured":"Myers LC, Murray R, Donato B, Liu VX, Kipnis P, Shaikh A, Franchino-Elder J. Risk of hospitalization in a sample of COVID-19 patients with and without chronic obstructive pulmonary disease. Respir Med. 2023. https:\/\/doi.org\/10.1016\/j.rmed.2022.107064.","journal-title":"Respir Med"},{"key":"22041_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261772","author":"M Amital","year":"2021","unstructured":"Amital M, Ben-Shabat N, Amital H, Buskila D, Cohen AD, Amital D. COVID-19 associated hospitalization in 571 patients with fibromyalgia\u2014A population-based study. PLoS ONE. 2021. https:\/\/doi.org\/10.1371\/journal.pone.0261772.","journal-title":"PLoS ONE"},{"key":"22041_CR28","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.05.066","author":"DJ Lukin","year":"2020","unstructured":"Lukin DJ, Kumar A, Hajifathalian K, Sharaiha RZ, Scherl EJ, Longman RS, Jill Roberts Center Study Group, Weill Cornell Medicine-Gastrointestinal Study Group. Baseline disease activity and steroid therapy stratify risk of COVID-19 in patients with inflammatory bowel disease. Gastroenterology. 2020. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.066.","journal-title":"Gastroenterology"},{"key":"22041_CR29","unstructured":"Biddle N, Korda R. The experience of COVID-19 in Australia, including long-COVID - Evidence from the COVID-19 Impact Monitoring Survey Series, August 2022. ANU Centre for Social Research and Methods. 2022. https:\/\/csrm.cass.anu.edu.au\/sites\/default\/files\/docs\/2022\/10\/The_experience_of_COVID-19_in_Australia_-_For_web.pdf. Accessed Oct 30 2024."},{"key":"22041_CR30","unstructured":"National Center for Health Statistics. U.S. Census Bureau, Household Pulse Survey, 2022\u20132024. Long COVID [Internet]. US: CDC; 2024 [cited 2024 Oct 30]. Available from: https:\/\/www.cdc.gov\/nchs\/covid19\/pulse\/long-covid.htm"},{"key":"22041_CR31","unstructured":"Office for National Statistics. Coronavirus (COVID-19) Infection Survey: technical data [Internet]. UK: ONS. 2023 [cited 2024 Oct 30]. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/conditionsanddiseases\/datasets\/covid19infectionsurveytechnicaldata"},{"key":"22041_CR32","unstructured":"Statistics Canada. Canadian COVID-19 Antibody and Health Survey (CCAHS) [Internet]. Ottawa: Statistics Canada. 2024 [cited 2024 Mar 1]. Available from: https:\/\/www23.statcan.gc.ca\/imdb\/p2SV.pl?Function=getSurvey%26Id=1480441"},{"key":"22041_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-24307-1","author":"SB Larsson","year":"2022","unstructured":"Larsson SB, von Feilitzen GS, Andersson ME, Sikora P, Lindh M, Nord\u00e9n R, Nilsson S, Sigstr\u00f6m R. Self-reported symptom severity, general health, and impairment in post-acute phases of COVID-19: retrospective cohort study of Swedish public employees. Sci Rep. 2022. https:\/\/doi.org\/10.1038\/s41598-022-24307-1.","journal-title":"Sci Rep"},{"key":"22041_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.09.011","author":"P Eloy","year":"2021","unstructured":"Eloy P, Tardivon C, Martin-Blondel G, Isnard M, Le Turnier P, Le Marechal M, Cabi\u00e9 A, Launay O, Tattevin P, Senneville E, Ansart S, Goehringer F, Chirouze C, Bousson L, Laou\u00e9nan C, Etienne M, Nguyen D, Ghosn J, Duval X. Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study. Int J Infect Dis. 2021. https:\/\/doi.org\/10.1016\/j.ijid.2021.09.011.","journal-title":"Int J Infect Dis"},{"key":"22041_CR35","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S104807","author":"A Althubaiti","year":"2016","unstructured":"Althubaiti A. Information bias in health research: definition, pitfalls, and adjustment methods. J Multidisciplinary Healthc. 2016. https:\/\/doi.org\/10.2147\/JMDH.S104807.","journal-title":"J Multidisciplinary Healthc"},{"key":"22041_CR36","unstructured":"Statistics Canada. Index of Remoteness, 2016 [Internet]. Ottawa: Statistics Canada. 2024. Available from: https:\/\/www150.statcan.gc.ca\/n1\/en\/catalogue\/1710014301"},{"key":"22041_CR37","unstructured":"Statistics Canada. The Canadian Index of Multiple Deprivation: User Guide [Internet]. Ottawa: Statistics Canada. 2019 [cited 2024 Mar 1]. Available from: https:\/\/publications.gc.ca\/collections\/collection_2019\/statcan\/452000012019002-eng.pdf"},{"key":"#cr-split#-22041_CR38.1","unstructured":"Government of Canada. TCPS 2. (2022) - Chap. 2: Scope and Approach. CA: Statistics Canada"},{"key":"#cr-split#-22041_CR38.2","unstructured":"2023 [cited 2024 Mar 1]. Available from: https:\/\/ethics.gc.ca\/eng\/tcps2-eptc2_2022_chapter2-chapitre2.html#intro"},{"key":"22041_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241955","author":"A Izcovich","year":"2020","unstructured":"Izcovich A, Ragusa MA, Tortosa F, Lavena Marzio MA, Agnoletti C, Bengolea A, Ceirano A, Espinosa F, Saavedra E, Sanguine V, Tassara A, Cid C, Catalano HN, Agarwal A, Foroutan F, Rada G. Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review. PLoS ONE. 2020. https:\/\/doi.org\/10.1371\/journal.pone.0241955.","journal-title":"PLoS ONE"},{"key":"22041_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100747","author":"RA Evans","year":"2023","unstructured":"Evans RA, Dube S, Lu Y, Yates M, Arnetorp S, Barnes E, Bell S, Carty L, Evans K, Graham S, Justo N, Moss P, Venkatesan S, Yokota R, Ferreira C, McNulty R, Taylor S, Quint JK. Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study. Lancet Reg Health Europe. 2023. https:\/\/doi.org\/10.1016\/j.lanepe.2023.100747.","journal-title":"Lancet Reg Health Europe"},{"key":"22041_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00593-3","author":"EPK Parker","year":"2022","unstructured":"Parker EPK, Desai S, Marti M, Nohynek H, Kaslow DC, Kochhar S, O\u2019Brien KL, Hombach J, Wilder-Smith A. Response to additional COVID-19 vaccine doses in people who are immunocompromised: a rapid review. Lancet Glob Health. 2022. https:\/\/doi.org\/10.1016\/S2214-109X(21)00593-3.","journal-title":"Lancet Glob Health"},{"key":"22041_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.949787","author":"E Apostolou","year":"2022","unstructured":"Apostolou E, Rizwan M, Moustardas P, Sj\u00f6gren P, Bertilson BC, Brag\u00e9e B, Polo O, Ros\u00e9n A. Saliva antibody-fingerprint of reactivated latent viruses after mild\/asymptomatic COVID-19 is unique in patients with myalgic-encephalomyelitis\/chronic fatigue syndrome. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.949787.","journal-title":"Front Immunol"},{"key":"22041_CR43","doi-asserted-by":"publisher","unstructured":"Fialho MFP, Brum ES, Oliveira SM. Could the fibromyalgia syndrome be triggered or enhanced by COVID-19? Inflammopharmacology. 2023; https:\/\/doi.org\/10.1007\/s10787-023-01160-w","DOI":"10.1007\/s10787-023-01160-w"},{"key":"22041_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4","author":"EJ Williamson","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, Bacon S, Bates C, Morton CE, Curtis HJ, Mehrkar A, Evans D, Inglesby P, Cockburn J, McDonald HI, MacKenna B, Tomlinson L, Douglas IJ, Rentsch CT, Mathur R, Wong AYS, Grieve R, Harrison D, Forbes H, Schultze A, Croker R, Parry J, Hester F, Harper S, Perera R, Evans SJW, Smeeth L, Goldacre B. Factors associated with COVID-19-related death using opensafely. Nature. 2020. https:\/\/doi.org\/10.1038\/s41586-020-2521-4.","journal-title":"Nature"},{"key":"22041_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m3731","author":"AK Clift","year":"2020","unstructured":"Clift AK, Coupland CAC, Keogh RH, Diaz-Ordaz K, Williamson E, Harrison EM, Hayward A, Hemingway H, Horby P, Mehta N, Benger J, Khunti K, Spiegelhalter D, Sheikh A, Valabhji J, Lyons RA, Robson J, Semple MG, Kee F, Johnson P, Jebb S, Williams T, Hippisley-Cox J. Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: National derivation and validation cohort study. BMJ. 2020. https:\/\/doi.org\/10.1136\/bmj.m3731.","journal-title":"BMJ"},{"key":"22041_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s13048-020-00734-4","author":"J O\u2019Brien","year":"2020","unstructured":"O\u2019Brien J, Du KY, Peng C. Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age. J Ovarian Res. 2020. https:\/\/doi.org\/10.1186\/s13048-020-00734-4.","journal-title":"J Ovarian Res"},{"key":"22041_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012581","author":"C Li","year":"2023","unstructured":"Li C, Islam N, Gutierrez JP, Guti\u00e9rrez-Barreto SE, Prado AC, Moolenaar RL, Lacey B, Richter P. Associations of diabetes, hypertension and obesity with COVID-19 mortality: a systematic review and meta-analysis. BMJ Global Health. 2023. https:\/\/doi.org\/10.1136\/bmjgh-2023-012581.","journal-title":"BMJ Global Health"},{"key":"22041_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06536-3","author":"ZG Dessie","year":"2021","unstructured":"Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021. https:\/\/doi.org\/10.1186\/s12879-021-06536-3.","journal-title":"BMC Infect Dis"},{"key":"22041_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-68356-0","author":"SH Ahn","year":"2024","unstructured":"Ahn SH, Seo SH, Jung CY, Yu DH, Kim Y, Cho Y, Seo DH, Kim SO, Yoo J, et al. Clinical outcomes of COVID-19 infection in patients with osteoporosis: a nationwide cohort study in Korea using the common data model. Sci Rep. 2024. https:\/\/doi.org\/10.1038\/s41598-024-68356-0.","journal-title":"Sci Rep"},{"key":"22041_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-024-05068-1","author":"R Huo","year":"2024","unstructured":"Huo R, Wei C, Huang X, Yang Y, Huo X, Meng D, Huang R, Huang Y, Zhu X, Yang Y, Lin J. Mortality associated with osteoporosis and pathological fractures in the united States (1999\u20132020): a multiple-cause-of-death study. J Orthop Surg Res. 2024. https:\/\/doi.org\/10.1186\/s13018-024-05068-1.","journal-title":"J Orthop Surg Res"},{"key":"22041_CR51","unstructured":"Public Health Agency of Canada. Osteoporosis and related fractures in Canada: Report from the Canadian Chronic Disease Surveillance System 2020 [Internet]. Ottawa: PHAC, 2020 [cited 2025 Feb 1]. Available from: https:\/\/www.canada.ca\/en\/public-health\/services\/publications\/diseases-conditions\/osteoporosis-related-fractures-2020.html#a3"},{"key":"22041_CR52","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012328","author":"P Relan","year":"2023","unstructured":"Relan P, Motaze NV, Kothari K, Askie L, Le Polain O, Van Kerkhove MD, Diaz J, Tirupakuzhi Vijayaraghavan BK. Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and meta-analysis. BMJ Global Health. 2023. https:\/\/doi.org\/10.1136\/bmjgh-2023-012328.","journal-title":"BMJ Global Health"},{"key":"22041_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00152-0","author":"DR Feikin","year":"2022","unstructured":"Feikin DR, Higdon MM, Abu-Raddad LJ, Andrews N, Araos R, Goldberg Y, Groome MJ, Huppert A, O\u2019Brien KL, Smith PG, Wilder-Smith A, Zeger S, Deloria Knoll M, Patel MK. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022. https:\/\/doi.org\/10.1016\/S0140-6736(22)00152-0.","journal-title":"Lancet"},{"key":"22041_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13020165","author":"L Lungaro","year":"2023","unstructured":"Lungaro L, Costanzini A, Manza F, Barbalinardo M, Gentili D, Guarino M, Caputo F, Zoli G, De Giorgio R, Caio G. Impact of female gender in inflammatory bowel diseases: A narrative review. J Pers Med. 2023. https:\/\/doi.org\/10.3390\/jpm13020165.","journal-title":"J Pers Med"},{"key":"22041_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03514-2","author":"DA Salem","year":"2024","unstructured":"Salem DA, El-Ijla R, AbuMusameh RR, Zakout KA, Abu Halima AY, Abudiab MT, Banat YM, Alqeeq BF, Al-Tawil M, Matar K. Sex-related differences in profiles and clinical outcomes of inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterol. 2024. https:\/\/doi.org\/10.1186\/s12876-024-03514-2.","journal-title":"BMC Gastroenterol"},{"key":"22041_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16218-1","author":"EC Dos Reis","year":"2023","unstructured":"Dos Reis EC, de Freitas Monteiro EL, Meneguci J, Rodrigues P, Palma A, Virtuoso Junior JS, Passos SRL, Borges Dos Santos MA. Body mass index and sex differences for mortality in hospitalized COVID-19 patients: a path analysis using a Brazilian National database. BMC Public Health. 2023. https:\/\/doi.org\/10.1186\/s12889-023-16218-1.","journal-title":"BMC Public Health"},{"key":"22041_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23417","author":"S Yamamoto","year":"2022","unstructured":"Yamamoto S, Mizoue T, Tanaka A, Oshiro Y, Inamura N, Konishi M, Ozeki M, Miyo K, Sugiura W, Sugiyama H, Ohmagari N. Sex-associated differences between BMI and SARS-CoV-2 antibody titers following the BNT162b2 vaccine. Obesity. 2022. https:\/\/doi.org\/10.1002\/oby.23417.","journal-title":"Obesity"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22041-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22041-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22041-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T17:12:02Z","timestamp":1741799522000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22041-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22041"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22041-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was exempt from research ethics board review under article 2.2 of the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans \u2013 TCPS 2 (2022).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Completion of the online questionnaire implied consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Sharing agreements prohibit the publication of participant data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"981"}}